A Novel Type of Cell Death of Lymphocytes Induced by mAb
A Novel Type of Cell Death of Lymphocytes Induced by mAb
批准号:
09670343
负责人:
MATSUOKA Shuji
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
单抗诱导淋巴细胞死亡的一种新类型我们已经建立了一种大鼠抗小鼠单抗RE2,它识别MHC I类单态区上的一个表位。在缺乏补体的情况下,RE2单抗可杀伤活化的淋巴细胞和白血病细胞系。在电子显微镜下,RE2处理的细胞膜上形成了巨大的孔洞。在细胞裂解过程中未见DNA断裂或线粒体肿胀的迹象,提示细胞死亡不是由于细胞凋亡或典型的坏死。我们研究了RE2单抗对易患自身免疫病的NZB/WF1小鼠淋巴细胞的影响。在体内和体外,RE2均能显著消除小鼠腹膜和脾中的BI细胞。在另一项实验中,我们还观察了RE2单抗对ConA诱导的肝炎的影响。RE2可完全抑制肝炎小鼠血清GOT、GPT的升高。RE2单抗只能杀死活化的淋巴细胞,而不能杀死静息细胞,这可能有助于我们开发一种治疗自身免疫性疾病、重型肝炎和淋巴瘤AS的装置。
英文摘要
A Novel Type of Cell Death of Lymphocytes Induced by mAbWe have established a rat anti-mouse mAb, RE2, which recognizes an epitope that is on an MHC class I monomorphic region. RE2 mAb killed activated lymphocytes and leukemic cell lines in the absence of complement. Electromicroscopically, formation of Giant holes was found on the cell membrane of RE2-treated cells. There was no indication of DNA fragmentation nor swelling of mitochondria during the cell lysis, suggesting that the cell death is not due to apoptosis or typical necrosis. We investigated the effect of RE2 mAb on lymphocytes from autoimmune disease prone NZB/W Fl mice. BI cells in the peritoneal cavity and spleen were drastically eliminated by treatment with RE2 both in vivo and in vitro. In the other experiment, We also investigated the effect of RE2 mAb on Con A induced hepatitis. RE2 completely inhibited the elevation of serum GOT and GPT of the hepatitis induced mouse. RE2 mAb kills only activated lymphocytes but resting cells, it may help us to develop a therapeutic device for autoimmune diseases, Fulminant Hepatitis and lymphom as.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Shuji Matsuoka et al.: "A Novel type of cell death of lymphocytes Induced by a monoclonal antibody without participation of complement." J.Exp.Med.Vol.181. 2007-2015 (1995)
Shuji Matsuoka 等人:“一种由单克隆抗体诱导的新型淋巴细胞死亡,无需补体参与。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Establishment of therapeutic mAbs for malignant lymphoma
-
批准号:15K06880
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2015
-
负责人:MATSUOKA Shuji
-
依托单位:
A Novel Type of Cell Death of Lymphocytes induced by mAb
-
批准号:12670307
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2000
-
负责人:MATSUOKA Shuji
-
依托单位:
国内基金
海外基金
基于PAR1介导的MHC class I表达探讨血府逐瘀汤逆转肺癌免疫逃逸的作用及机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:李燕
-
依托单位: